Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12326031
[patent_doc_number] => 09944660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Tricyclic benzoxaboroles as antibacterial agents
[patent_app_type] => utility
[patent_app_number] => 15/393996
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14952
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393996
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393996 | Tricyclic benzoxaboroles as antibacterial agents | Dec 28, 2016 | Issued |
Array
(
[id] => 14516335
[patent_doc_number] => 10335401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Non-aromatic heterocyclic derivative having MGAT2 inhibitory activity
[patent_app_type] => utility
[patent_app_number] => 16/061155
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21588
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061155 | Non-aromatic heterocyclic derivative having MGAT2 inhibitory activity | Dec 20, 2016 | Issued |
Array
(
[id] => 11541620
[patent_doc_number] => 20170095445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG'
[patent_app_type] => utility
[patent_app_number] => 15/387532
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12723
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15387532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/387532 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG | Dec 20, 2016 | Abandoned |
Array
(
[id] => 13732989
[patent_doc_number] => 20180370962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => NOVEL 1,2,3 TRIAZOLE-THIAZOLE COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/064415
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064415 | 1,2,3 triazole-thiazole compounds, process for preparation and use thereof | Dec 19, 2016 | Issued |
Array
(
[id] => 13777705
[patent_doc_number] => 20190002391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/064377
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064377 | Metabolism resistant fenfluramine analogs and methods of using the same | Dec 19, 2016 | Issued |
Array
(
[id] => 13732849
[patent_doc_number] => 20180370892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/063201
[patent_app_country] => US
[patent_app_date] => 2016-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063201 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | Dec 16, 2016 | Issued |
Array
(
[id] => 16429360
[patent_doc_number] => 10829427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Naphthoquinones, pro-drugs, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/063347
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 27331
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063347 | Naphthoquinones, pro-drugs, and methods of use thereof | Dec 15, 2016 | Issued |
Array
(
[id] => 13276527
[patent_doc_number] => 10149829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Treatment of circadian rhythm disorders
[patent_app_type] => utility
[patent_app_number] => 15/382526
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 18760
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382526 | Treatment of circadian rhythm disorders | Dec 15, 2016 | Issued |
Array
(
[id] => 13551723
[patent_doc_number] => 20180327409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => CXCR4 RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/776936
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776936 | CXCR4 receptor antagonists | Dec 13, 2016 | Issued |
Array
(
[id] => 11527147
[patent_doc_number] => 20170087123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'TREATMENT OF CIRCADIAN RHYTHM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/378353
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20803
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15378353
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/378353 | Treatment of circadian rhythm disorders | Dec 13, 2016 | Issued |
Array
(
[id] => 13622017
[patent_doc_number] => 20180362560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => PEGYLATED IMIDAZOQUINOLINES
[patent_app_type] => utility
[patent_app_number] => 15/781905
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781905 | Pegylated imidazoquinolines | Dec 11, 2016 | Issued |
Array
(
[id] => 16321228
[patent_doc_number] => 10781184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Substituted benzazinones as antibacterial compounds
[patent_app_type] => utility
[patent_app_number] => 16/060641
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60972
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060641 | Substituted benzazinones as antibacterial compounds | Dec 7, 2016 | Issued |
Array
(
[id] => 11527564
[patent_doc_number] => 20170087542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'HYDROFORMYLATION CATALYST'
[patent_app_type] => utility
[patent_app_number] => 15/372934
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372934
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372934 | Hydroformylation catalyst | Dec 7, 2016 | Issued |
Array
(
[id] => 11514243
[patent_doc_number] => 20170081315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'Phenyl and benzodioxinyl substituted indazoles derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/367936
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19942
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367936 | Phenyl and benzodioxinyl substituted indazoles derivatives | Dec 1, 2016 | Issued |
Array
(
[id] => 13589743
[patent_doc_number] => 20180346420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => CARBON MONOXIDE RELEASING NORBORNENONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/779929
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779929 | Carbon monoxide releasing norbornenone compounds | Nov 29, 2016 | Issued |
Array
(
[id] => 14294639
[patent_doc_number] => 10287436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Process for the preparation of indocyanine green
[patent_app_type] => utility
[patent_app_number] => 15/780555
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1802
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780555 | Process for the preparation of indocyanine green | Nov 28, 2016 | Issued |
Array
(
[id] => 14454153
[patent_doc_number] => 10323028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => 1,3,4-thiadiazole compounds and their use in treating cancer
[patent_app_type] => utility
[patent_app_number] => 15/363030
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21493
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15363030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/363030 | 1,3,4-thiadiazole compounds and their use in treating cancer | Nov 28, 2016 | Issued |
Array
(
[id] => 13732959
[patent_doc_number] => 20180370947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => FACTOR XIa INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/780134
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780134 | Factor XIa inhibitors | Nov 28, 2016 | Issued |
Array
(
[id] => 14422383
[patent_doc_number] => 10315981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Process for preparing a diaryl carbonate
[patent_app_type] => utility
[patent_app_number] => 15/778944
[patent_app_country] => US
[patent_app_date] => 2016-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2391
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778944
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778944 | Process for preparing a diaryl carbonate | Nov 23, 2016 | Issued |
Array
(
[id] => 13093295
[patent_doc_number] => 10065978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use
[patent_app_type] => utility
[patent_app_number] => 15/360139
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 3398
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/360139 | Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use | Nov 22, 2016 | Issued |